top of page

Wide_PrimaryAlt3 Padding.png

About Biotech CEO Sisterhood

About the show: Members of the Biotech CEO Sisterhood regularly interview women leaders in biotech about news, science, management topics and more. Tune in to hear from top leaders in biotech about topics that matter to the industry.

Editorial Board Members

Angie You

Bio

Daphne Zohar

Bio

Erika Smith

Bio

Grace Colón

Bio

Julia Owens

Bio

Luba Greenwood

Bio

Sheila Gujrathi

Bio

About the Sisterhood

The Biotech CEO Sisterhood is a vibrant community dedicated to championing the success of women leaders in the biopharma industry. Rooted in a culture of mutual support and authenticity, the Sisterhood aims to inspire and uplift women while driving meaningful conversations and impact across the industry. As part of our commitment to nurturing the current and future generations of biotech leaders, the Sisterhood hosts summits, local events, and educational sessions. These programs encourage dialogue about the challenges facing women in biotech, share best practices, and enhance leadership effectiveness. Since its inception in 2022, the Biotech CEO Sisterhood has grown to 300+ members. To follow our progress and learn more, please follow us on LinkedIn.

Episodes

Biotech CEO Sisterhood: Kate Haviland discusses the success factors that led to the $9B+ acquisition of Blueprint Medicines, and the trend of biotech companies taking commercial assets further | 12/15/25

Kate Haviland discusses the success factors that led to the $9B+ acquisition of Blueprint Medicines, and the trend of biotech companies taking commercial assets further

Biotech CEO Sisterhood: EpiBone creates bones and cartilage grown from stem cells - Co-Founder and CEO Nina Tandon describes the creative thinking she has used to accelerate its availability | 12/11/25

EpiBone creates bones and cartilage grown from stem cells - Co-Founder and CEO Nina Tandon describes the creative thinking she has used to accelerate its availability

Biotech leader Sheila Gujrathi discusses her new book, The Mirror Effect, which she wrote for her younger self, today's peers, and the next generation of female leaders in business | 12/2/25

Biotech leader Sheila Gujrathi discusses her new book, The Mirror Effect, which she wrote for her younger self, today's peers, and the next generation of female leaders in business

Biotech CEO Sisterhood: Stealth BioTherapeutics' CEO Reenie McCarthy describes the fortitude and close relationship with a patient community that lead to the first approved therapy for Barth Syndrome | 11/13/25

Stealth BioTherapeutics' CEO Reenie McCarthy describes the fortitude and close relationship with a patient community that led to the first approved therapy for Barth Syndrome

Biotech CEO Sisterhood: Hanadie Yousef leads Juvena Therapeutics, a company is developing protein based therapeutics that are tissue restorative for muscle and metabolic diseases | 09/04/25

Hanadie Yousef leads Juvena Therapeutics, a company developing protein based therapeutics that are tissue restorative for muscle and metabolic diseases

Biotech CEO Sisterhood: Catherine Pickering is leading iOnctura, which is focused on solving the problem of cancer resistance both at the tumor and around its environment | 09/04/25

Catherine Pickering leads iOnctura, which is focused on solving cancer resistance both at the tumor and its environment

Biotech CEO Sisterhood: Sheila Gujrathi is an experienced leader in biotech, a co-founder of the Biotech CEO Sisterhood, and has a new book coming out next month | 09/04/25

Sheila Gujrathi is a leader, a co-founder of the Biotech CEO Sisterhood, and has a new book coming out next month

Biotech CEO Sisterhood: Stacy Blain is the Founder and CEO of Concarlo Therapeutics, which is the first company to target CDK4/6-driven cell proliferation and CDK2-driven resistance | 09/04/25

Stacy Blain is the Founder of Concarlo Therapeutics, which is the 1st company to target both CDK4/6 and CDK2

Biotech CEO Sisterhood: Catherine Sabatos-Peyton is running Larkspur Biosciences, a company targeting cancer cell fitness | 09/04/25

Catherine Sabatos-Peyton is leading Larkspur Biosciences, a company targeting cancer cell fitness

Biotech CEO Sisterhood: Kiran Mazumdar-Shaw, builder of India's leading biotech enterprise and a pioneer in the development of biologics and biosimilars, shares her story and learnings from business | 09/02/25

Kiran Mazumdar-Shaw on building India's leading biotech enterprise and learnings from her career in business

Biotech CEO Sisterhood: Ivana Liebisch on her career path, the successful sale of Vigil to Sanofi, moving quickly and decisively on decisions, and her thoughts on leadership | 08/19/25

Ivana Liebisch on her career path, the successful sale of Vigil to Sanofi, moving quickly and decisively on decisions, and her thoughts on leadership

Biotech CEO Sisterhood: Trevi Therapeutics' Co-Founder & CEO Jennifer Good on good communication and capital efficiency, and a unique internship program in life sciences | 08/06/25

Trevi Therapeutics' Co-Founder & CEO Jennifer Good on effective communication and capital efficiency, and a unique internship program in life sciences

Biotech CEO Sisterhood: As CEO, Sophie Kornowski sold Boston Pharmaceuticals to GSK earlier this year for up to $2 billion. She shares her thoughts on the biopharma business and on leadership | 07/18/25

As CEO, Sophie Kornowski sold Boston Pharmaceuticals to GSK earlier this year for up to $2 billion. She shares her thoughts on the biopharma business and leadership

Biotech CEO Sisterhood: Daré Bioscience's Founder & CEO Sabrina Johnson describes her company's mission to make women's health a priority | 05/06/25

Daré Bioscience's Founder & CEO Sabrina Johnson describes her company's mission to make women's health a priority

Biotech CEO Sisterhood: Named CEO of Acadia Pharmaceuticals in September, Catherine Owen Adams describes taking the leap from a career in 'pharma' to running an independent, commercial stage biotech | 04/22/25

Catherine Owen Adams describes taking the leap from a career in 'pharma' to running an independent, commercial stage biotech

Biotech CEO Sisterhood: X4 Pharmaceuticals' CEO Paula Ragan on her career and running a commercial stage company in the rare disease space | 04/08/25

X4 Pharmaceuticals' CEO Paula Ragan on her career and running a commercial stage company in the rare disease space

Biotech CEO Sisterhood: Gallop Oncology CEO Luba Greenwood on the importance of the Sisterhood, the Massachusetts life sciences ecosystem, and the work at Gallop | 03/27/25

Gallop Oncology CEO Luba Greenwood on the importance of the Sisterhood, the Massachusetts life sciences ecosystem, and Gallop's work

Biotech CEO Sisterhood: Alnylam CEO Yvonne Greenstreet on her career path, the importance of diversity of opinions, and leading Alnlyam into a critical phase of growth | 03/17/25

Alnylam CEO Yvonne Greenstreet on her career path, the importance of diversity of opinions, and leading Alnlyam into a critical phase of growth

Biotech CEO Sisterhood Vir's CEO Marianne De Backer describes her background and leadership style, and joining Vir as it experienced a road bump, but turning it into an opportunity via a key IO deal | 03/03/25

Marianne De Backer's background and leadership style, and executing a key IO deal at Vir at an important time

Biotech CEO Sisterhood: Serial entrepreneur Sheila Mikhail on overcoming obstacles and getting the job done, including multiple major buyouts in her own career | 02/18/25

Serial entrepreneur Sheila Mikhail on overcoming obstacles and getting the job done, including multiple major acquisitions in her own career

Biotech CEO Sisterhood: Avidity Biosciences' CEO Sarah Boyce discusses a leader's responsibility to address dysfunction and the importance of corporate culture | 02/04/25

Avidity Biosciences' CEO Sarah Boyce discusses a leader's responsibility to address dysfunction and the importance of corporate culture

Biotech CEO Sisterhood: Mary Lynne Hedley shares advice on board makeup, running board meetings, and other factors into having an effective board of directors | 01/21/25

Mary Lynne Hedley shares advice on board makeup, running meetings, and other factors into having an effective board of directors

Biotech CEO Sisterhood: A leadership series discussion on building an effective board, best practices for running meetings, hiring talent, and decision making | 01/06/24

A leadership series discussion on building an effective board, best practices for running meetings, hiring talent, and decision making

Biotech CEO Sisterhood: Heather Turner and Sheila Gujrathi discuss managing your board of directors effectively | 12/19/24

Heather Turner and Sheila Gujrathi discuss managing your board of directors effectively

Biotech CEO Sisterhood: Melinta Therapeutics CEO Christine Miller on expanding the company into the acute care business, improving employee satisfaction, and her leadership principles | 12/12/24

Melinta Therapeutics CEO Christine Miller on expanding the company into the acute care business, improving employee satisfaction, and her leadership principles

Biotech veteran Deborah Dunsire on trends in drug development, investments, regulation, and her advice on key skills for growing into position of leadership | 12/5/24

Deborah Dunsire on trends in drug development, investments, regulation, and her advice on key skills for growing into position of leadership

The Sisterhood in their own words

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page